Case Comprehensive Cancer Center

The Alumni Association of Case Western Reserve University will host the next installment of Spartans Step Up, a webcast series focusing on topical issues and the CWRU community, Wednesday, Sept. 18, from 1 to 2 p.m. Gary Schwartz, director of the Case Comprehensive Cancer Center and vice dean of…

At 4 years old, Charis Eng was captivated by her uncle’s career as a physician—an early fascination that wound up shaping her future. By age 16, she had already enrolled at the University of Chicago, marking the start of a journey that would eventually lead her to become a pioneering figure in…

Robert Salata, MD, member of Case CCC's Population and Cancer Prevention Program, leading figure in the field of infectious diseases, and dedicated advocate for public health, passed away this week. His distinguished career at CWRU and University Hospitals spanned decades, during which he mentored…

A study published in Nature's Scientific Reports by Case CCC Molecular Oncology Program members Edward Plow, PhD, and Khalid Sossey-Alaoui, PhD, suggests that Kindlin-2 should be closely examined as a therapeutic target for prostate cancer treatment. Titled Role of Kindlin 2 in prostate cancer,…

Hsin-Ti (Cindy) Lin, MD, and Benjamin Liu, MD, both Residents at MetroHealth, were interviewed by National Public Radio's (NPR) health correspondent, Yuki Noguchi, about their research on the promise of GLP-1 agonists, a class of drugs now being used to treat diabetes and weight loss, for use in…

January 2022 debuted Reshmi Parameswaran's novel B-cell activating factor (BAFF) CAR T product effective at killing multiple B-cell cancers with robust in vitro and in vivo cytotoxicity exerted by these cells against mantle cell lymphoma, multiple myeloma, and acute lymphoblastic leukemia. This…

If you haven't met Faye Gary, EdD, RN, FAAN, you should. A tiny bundle of energy, she exudes compassion while commanding a room of high schoolers or an auditorium of her peers. She rarely takes "no" for an answer, and she gets things done. Gary, a CWRU Distinguished University Professor, is one of…

Case CCC Molecular Oncology Program member Khalid Sossey-Alaoui, PhD, and Thomas Jefferson University's Lucia Languino, PhD, conducted a collaborative study that appears in a recent Journal of Extracellular Vesicles. The study, Expression of the αVβ3 integrin affects prostate cancer sEV cargo and…

Daniel Spratt, MD, member of Case CCC's Developmental Therapeutics Program, conducted a retrospective cohort study assessing the associations between the Decipher Genomic Classifier (Decipher GC), a test that improves understanding of the aggressiveness of a patient's prostate cancer, and risks of…

Case Comprehensive Cancer Center (Case CCC) and Cleveland Metroparks have partnered to make it easier for people to prevent skin cancer. Free sunscreen will be available to all visitors at participating Cleveland Metroparks beaches and golf courses. The project, “Be Sun Smart. Protect Your Skin…